Researchers at the University of Missouri have developed a test that detects Rocky Mountain spotted fever in 40 minutes, a significant improvement over current diagnostic methods that can take days or require expensive equipment. The breakthrough addresses a critical gap in public health, particularly in regions where tick-borne illnesses are prevalent but medical infrastructure is limited. Traditional diagnostics often rely on techniques such as polymerase chain reaction (PCR) or immunofluorescence assays, which demand trained personnel, precise temperature control, and sophisticated machinery. These requirements create barriers in remote or low-resourced settings, where delays in diagnosis can lead to severe complications or fatalities.
Faster results could save lives
The disease, caused by the bacterium Rickettsia rickettsii, can progress rapidly. Symptoms—fever, headache, and rash—often appear within days of a tick bite, but these early signs are frequently mistaken for common viral infections like the flu. As the infection advances, it can trigger systemic inflammation, damaging blood vessels and leading to organ failure. Children under 10 and older adults are especially vulnerable, as their immune systems may struggle to contain the bacteria’s spread.
Existing tests either lack sensitivity or depend on advanced lab infrastructure, limiting their use in rural or under-resourced areas. For example, serological tests, which detect antibodies against R. rickettsii, may not yield results until a week after infection, by which time the disease may have already caused irreversible harm. Other methods, such as cell culture, are time-consuming and require biosafety level 3 facilities, which are rare outside major urban centers. The new method simplifies the process, requiring only a blood sample, specialized reagents, and a visual color change to confirm infection. This approach eliminates the need for centrifugation, thermal cycling, or fluorescence detection, making it feasible for use in clinics with minimal laboratory capabilities.
Roman Ganta, a professor at Mizzou’s College of Veterinary Medicine and lead investigator, emphasized the stakes. “Unfortunately, this disease can be particularly deadly in children if diagnosis is delayed,” he said. “Often patients may not realize they have been bitten by a tick until they feel extremely ill.” Tick bites are frequently painless, and the tiny arachnids may detach before symptoms appear, leaving patients unaware of their exposure. In some cases, the characteristic rash—a key diagnostic clue—fails to develop, further complicating early detection.
A test designed for accessibility
The procedure involves two 20-minute steps, both performed at room temperature without specialized machinery. The test, which involves mixing DNA from a sample with specialized reagents in two quick, 20-minute steps, can be completed at room temperature without the need for complex and costly laboratory equipment. After 40 minutes, a change in liquid color indicates a positive detection of the bacteria.
Doxycycline, the standard treatment, is most effective when administered early. Clinicians frequently prescribe it based on symptoms alone while awaiting lab results, but delays can worsen outcomes. The antibiotic works by inhibiting bacterial protein synthesis, halting the spread of R. rickettsii within the body. The new test’s rapid turnaround could enable clinicians to confirm infections before symptoms escalate, reducing the reliance on empirical treatment and improving patient prognosis.
Related: Blurry letters could signal hidden vision issues
Ganta’s team is exploring how to integrate the method into real-world settings. Discussions are underway with the Veterinary Medical Diagnostic Laboratory at Mizzou to assess its potential for clinical use. The laboratory, which serves as a reference center for animal and zoonotic diseases, could provide a testing ground for evaluating the method’s performance in diverse samples. If adopted, the test could expand access to timely diagnoses in areas where advanced lab equipment is scarce.
“By making this test more accessible, more patients can benefit from our work one day,” Ganta said. The team is also investigating ways to stabilize the reagents for transport and storage, as some components may degrade under extreme temperatures or prolonged exposure to light. Ensuring the test’s reliability in varied environmental conditions will be essential for its deployment in field clinics or mobile health units.
The study, published in Frontiers in Microbiology, reflects a broader effort to address diagnostic challenges in tick-borne illnesses. Similar rapid tests have emerged for Lyme disease in recent years, though none have matched the speed or simplicity of this approach. For instance, some Lyme disease diagnostics rely on lateral flow assays, which provide results in under an hour but may lack the sensitivity to detect early-stage infections. Others require refrigeration or additional processing steps, limiting their utility in resource-constrained environments. The new Rocky Mountain spotted fever test distinguishes itself by combining speed, ease of use, and minimal equipment requirements, making it a promising candidate for widespread adoption.
Whether it gains traction will depend on further validation and regulatory approval. The next phase of research will involve clinical trials to compare the test’s accuracy against gold-standard methods, such as PCR and immunofluorescence. Researchers will also need to demonstrate its performance across different populations. Regulatory bodies, such as the U.S. Food and Drug Administration or the World Health Organization, will require robust data on sensitivity, specificity, and reproducibility before approving the test for routine use.
For now, the focus remains on refining the method and proving its reliability outside controlled lab conditions. If successful, it could become a tool for frontline healthcare workers, particularly in regions where Rocky Mountain spotted fever is endemic but resources are limited. The test’s potential extends beyond human medicine; veterinarians could also use it to diagnose infections in dogs, which are highly susceptible to the disease and often serve as sentinels for human exposure. By bridging the gap between laboratory innovation and real-world application, this research could transform how tick-borne diseases are managed.